Advertisement
Screener

PMGC HOLDINGS INC. (ELAB) Disposal Group, Including Discontinued Operation, Gross Profit (Loss)

0.0 / 5 stars · 0/14 Roast Me

PMGC HOLDINGS INC. Disposal Group, Including Discontinued Operation, Gross Profit (Loss)

PMGC HOLDINGS INC. (ELAB) reported Disposal Group, Including Discontinued Operation, Gross Profit (Loss) of $121.85 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss · last filed 2026-08-14

  • PMGC HOLDINGS INC. disposal group, including discontinued operation, gross profit (loss) for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
  • PMGC HOLDINGS INC. disposal group, including discontinued operation, gross profit (loss) for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
  • PMGC HOLDINGS INC. disposal group, including discontinued operation, gross profit (loss) for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
  • PMGC HOLDINGS INC. disposal group, including discontinued operation, gross profit (loss) for the quarter ending 2025-03-31 was $121.85K, a 72.66% decline year-over-year.
  • PMGC HOLDINGS INC. disposal group, including discontinued operation, gross profit (loss) for fiscal 2025 was $121.85K, a 93.22% decline from fiscal 2024.
  • PMGC HOLDINGS INC. disposal group, including discontinued operation, gross profit (loss) for fiscal 2024 was $1.80M, a 58.39% increase from fiscal 2023.
  • PMGC HOLDINGS INC. disposal group, including discontinued operation, gross profit (loss) for fiscal 2023 was $1.13M.
Period endDisposal Group, Including Discontinued Operation, Gross Profit (Loss) 3 monthDisposal Group, Including Discontinued Operation, Gross Profit (Loss) 6 monthDisposal Group, Including Discontinued Operation, Gross Profit (Loss) 9 monthDisposal Group, Including Discontinued Operation, Gross Profit (Loss) 12 month
2025-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30
$0.00
derived: sum of 2 quarters · filed 2026-03-30
$0.00
derived: sum of 3 quarters · filed 2026-08-14
$121.85K
10-K · filed 2026-03-30
2025-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14
$0.00
derived: sum of 2 quarters · filed 2026-08-14
$121.85K
10-Q · filed 2025-11-14
$640.14K
derived: sum of 4 quarters · filed 2026-08-14
2025-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14
$121.85K
10-Q · filed 2026-08-14
$640.14K
derived: sum of 3 quarters · filed 2026-08-14
$1.03M
derived: sum of 4 quarters · filed 2026-08-14
2025-03-31$121.85K
10-Q · filed 2026-05-15
$640.14K
derived: sum of 2 quarters · filed 2026-05-15
$1.03M
derived: sum of 3 quarters · filed 2026-05-15
$1.47M
derived: sum of 4 quarters · filed 2026-05-15
2024-12-31$518.29K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30
$912.19K
derived: sum of 2 quarters · filed 2026-03-30
$1.35M
derived: sum of 3 quarters · filed 2026-03-30
$1.80M
10-K · filed 2026-03-30
2024-09-30$393.90K
10-Q · filed 2025-11-14
$833.15K
derived: sum of 2 quarters · filed 2025-11-14
$1.28M
10-Q · filed 2025-11-14
2024-06-30$439.26K
10-Q · filed 2025-08-13
$884.91K
10-Q · filed 2025-08-13
2024-03-31$445.65K
10-Q · filed 2025-05-14
2023-12-31$1.13M
10-K · filed 2025-03-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
FILANA THERAPEUTICS, INC. (FLNA)United States$0.038B-1.05
Actinium Pharmaceuticals, Inc. (ATNM)United States$0.038B2.73
Celularity Inc (CELU)United States$0.038B-0.34
BriaCell Therapeutics Corp. (BCTX)$0.037B
CervoMed Inc. (CRVO)United States$0.038B-1.39
Seres Therapeutics, Inc. (MCRB)United States$0.036B-3.45
Edesa Biotech, Inc. (EDSA)Canada$0.039B
MIRA PHARMACEUTICALS, INC. (MIRA)United States$0.036B-4.30
Karyopharm Therapeutics Inc. (KPTI)United States$0.039B-0.98
ROCKWELL MEDICAL, INC. (RMTI)United States$0.035B